Somite AI

About Somite AI

Somite is a company focused on building foundation models for the human cell, leveraging AI to pioneer a new era of human repair through cell replacement therapy.

Products & Services

Foundation Models for Human Cell:AI-driven models designed to advance human repair through innovative cell replacement therapies.

Specialties

AI in Biotechnology Cell Replacement Therapy Human Cell Modeling

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 47000000 MR: - FA: $47M FAN: 47000000	D: 2025-08-20 FD: 2025-08-20	2 investors
2	RT: Series A T: - FT: Series A	A: 47000000 MR: - FA: more than $47 million FAN: 47000000	D: 2025-05-13 FD: 2025-05-13	10 investors
3	RT: Pre-Seed T: - FT: Pre-Seed	A: 4800000 MR: - FA: 4.8M FAN: 4800000	D: 2024-09-03 FD: 2024-09-03	4 investors
4	RT: Pre-Seed T: - FT: Pre-Seed	A: 5300000 MR: - FA: $5.3M FAN: 5300000	D: 2024-04-16 FD: 2024-04-16	5 investors

Series A Latest

2025-08-20

$47.0M

2 investors (Pro only)

Series A 2025-05-13

$47.0M

Pre-Seed 2024-09-03

$4.8M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Somite AI Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised